Biopharma News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–12 of 15 articles
Socioeconomic status shapes children’s brain development, study finds
4 min
Dr. Sarah MitchellTakeda TYK2 drug tops Bristol Myers’ Sotyktu in psoriasis head-to-head test
psoriasis · 5 min
Dr. Sarah MitchellAstraZeneca expands obesity push as it invests $125M in ultrasound medicine
FDA · obesity · 5 min
Dr. Sarah MitchellTillomed Laboratories update: pipeline, melphalan and next catalysts
oncology · 6 min
Dr. Sarah MitchellWhy innovation alone is no longer enough in biopharma
4 min
Dr. Sarah MitchellSanofi completes Inhibrx acquisition for $1.7B
inflammation · 4 min
Dr. Sarah MitchellFierce Biotech Week 2026: Key Insights and Highlights
FDA · 6 min
Dr. Sarah MitchellVir Biotechnology Stock: Board Reshuffle and Governance Votes Post-AGM
FDA · 7 min
Dr. Sarah MitchellLongeveron Stockholder Letter Outlines 2026 Strategy and Partnership Focus
FDA · 6 min
Dr. Sarah MitchellAsia Surges as Biopharma Innovation Hub, Driving Global Drug Approvals
5 min
Dr. Sarah MitchellTop 10 Biopharma M&A Deals of 2025: Market Analysis
4 min
Dr. Sarah MitchellPharma Partnering US: $77.3B Licensing Deals in Q1 2026
biotech · 12 min
Dr. Sarah MitchellExplore intelligence